Elucid Company
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
Total Funding:
49728339.0
Headquarters:
Boston, Massachusetts, United States
Funding Status:
Early Stage Venture
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Last Funding Date:
2022-06-22
Investors Number:
14.0
Founded Date:
2013-01-01
Industry:
Clinical Development